A nonmalignant cancerous tumor affecting cranial nerve VIII that causes unilateral hearing loss, tinnitus, and vertigo is:

A. Otosclerosis
B. Acoustic neuroma
C. Cholesteatoma
D. Squamous cell carcinoma


ANS: B
With an acoustic neuroma, the onset of symptoms usually occurs after age 30. Early complaints include unilateral hearing loss, tinnitus, and vertigo. As the tumor advances, symptoms may include headache, facial pain, ataxia, nausea/vomiting, and lethargy. The ear structures appear normal. Cholesteatoma is not a cancer; it is a destructive and expanding growth consisting of keratinizing in the middle ear and/or mastoid process. The growth erodes the ossicles and can spread through the base of the skull into the brain. Otosclerosis involves degenerative changes to the bony structures of the middle ear and results in gradual onset of hearing deficit as the bones lose their vibratory ability. The patient typically complains of painless, progressive changes in hearing. Symptoms are usually bilateral, and tinnitus may be present. The physical examination is usually normal, with the exception of the hearing acuity test.

Nursing

You might also like to view...

What is the correct administration technique for sucralfate (Carafate)?

1. Administer it after meals. 2. Administer it prior to meals. 3. Administer the drug once daily. 4. Administer it with milk.

Nursing

A 40-year-old male client has arthritis of the knee joint and has been prescribed an

analgesic to relieve the pain. Which is a narcotic analgesic? A) Aspirin B) Ibuprofen C) Celecoxib D) Morphine

Nursing

The nurse is providing care to a patient who was admitted with a suspected Coumarin overdose. Which of the following blood products will most likely be included in the patient's plan of care?

1. Cryoprecipitate 2. Fresh frozen plasma 3. Whole blood 4. Albumin

Nursing

A client with hyperthyroidism is being treated with radioactive iodine (I-131). Which explanation should be included in preparing this client for this treatment?

a. describe radioactive iodine as a tasteless, colorless medication administered by the healthcare provider b. explain the need for using lead shields for 2 to 3 weeks after the treatment c. describe the signs of goiter because this is a common side effects of radioactive iodine d. explain that relief of the signs/ symptoms of hyperthyroidism will occur immediately

Nursing